The US Food and Drug Administration is moving as fast as possible to get to final approval of Pfizer/BioNTech’s coronavirus vaccine but doesn’t have a set date in mind, a federal official told CNN Tuesday.
The New York Times reported that the FDA was aiming to make a decision of full approval by Labor Day, citing multiple sources familiar with the matter.
“That’s an outside date. We don’t have a set date,” said the official, who asked not to be identified because they did not have approval to speak to the media about the matter.
FDA officials have said multiple times they are working as fast as they can to fully approve Pfizer’s vaccine, which is being distributed now under emergency use authorization. The FDA posted a statement last Friday saying it was pulling in help from across the agency, including “sprint teams,” to speed final approval.
“We have to make sure we dot all the i’s and cross all the t’s, or else people will say we did not do the approval correctly,” the official said.